Bibliography
- GEIER MR, GEIER DA, ZAHALSKY AC: A review of hepatitis B vaccination. Expert Opin. Drug Sal (2003) 2(2):113–122.
- DUCLOS P: Safety of immunisation and adverse events following vaccination against hepatitis B. Expert Opin. Drug Sal (2003) 2(3):225–231.
- GANGAROSA EJ, GALAZKA AM, WOLFE CR et al.: Impact of anti-vaccine movements on pertussis control: the untold story. Lancet (1998) 351(9099):356–361.
- CHEN RT, ORENSTEIN WA: Epidemiologic methods in immunization programs. Epidennol Rev (1996) 18(2):99–117.
- ••Excellent overview of the range of epidemiological study designs applied to vaccirtology.
- SINGLETON JA, LLOYD JC, MOOTREY GT, SALIVE ME, CHEN RT: An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group. Vaccine (1999) 17(22):2908–2917.
- ••Review of VAERS and its strengths andlimitations, using the principles of evaluating surveillance systems.
- SCHEIFELE DW, HALPERIN SA, GOLD R, SAMSON H AND MEMBERS OF THE CANADIAN PEDIATRIC SOCIETY/HEALTH CANADA IMMUNIZATION MONITORING PROGRAM, ACTIVE (IMPACT): Assuring vaccine safety: a celebration of 10 years of progress with the IMPACT project. Pediatr. Child Health (2002) 7(9).
- CHEN RT, DESTEFANO E DAVIS RL et al: The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA. Bull. World Health Organ. (2000) 78(2):186–194.
- ROBERTS JD, ROOS LL, POFFENROTH LA et al.: Surveillance of vaccine-related adverse events in the first year of life: a Manitoba cohort study. Clin. Epidennol. (1996) 49(1):51–58.
- LASKY T, TERRACCIANO GJ, MAGDER L et al.: The Guillain—Barre syndrome and the 1992 — 1993 and 1993-1994 influenza vaccines. N Engl. J. Med. (1998) 339(25):1797–1802.
- STRATTON K, ALMARIO DA, MCCORMICK MC: Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders. National Academies Press, Washington DC (2002). Available at: http://www.nap.edu/books/0309084695/ htmliindex.html
- •Covers hepatitis B vaccine and MS, and provides insight into how such concerns should be evaluated.
- HALSEY NA, DUCLOS P, VAN DAMME P, MARGOLIS H: Hepatitis B vaccine and central nervous system demyelinating diseases. Viral Hepatitis Prevention Board. Pediatr. Infect. Dis. J. (1999) 18:23–24.
- •Report of a working group convened as the allegation reached its peak.
- NO AUTHORS LISTED: Centers for Disease Control and Prevention: Reports No. 94 (1991 — 1995); Biologics surveillance.
- ZHOU W, POOL V, ISKANDER JK etaL: Surveillance for Safety after Immunization: Vaccine Adverse Event Reporting System (VAERS) — United States, 1991 — 2001. MMWR Morb. Mortal. Wkly Rep. (2003) 52:1–24.
- •Overview of reports to VAERS and their interpretation.